Odisha made Covid-19 rapid antigen test kit gets ICMR approval

The Indian Council of Medical Research has validated the COVID-19 rapid antigen test kit developed by a private company in Odisha.

coronavirus
Photo: PTI
Press Trust of India Bhubaneswar
2 min read Last Updated : Jan 29 2022 | 1:26 PM IST

The Indian Council of Medical Research (ICMR) has validated the COVID-19 rapid antigen test kit developed by a private company in Odisha.

The kit has been developed by IMGENEX India Pvt Ltd, Bhubaneswar with intellectual input from Regional Medical Research Centre (RMRC). The kit can detect various variants of COVID-19 by using nasopharyngeal swab samples.

RMRC director Dr Sanghamitra Pati said: The IMGENEX India Pvt Ltd, Bhubaneswar first started developing the kit and RMRC Bhubaneswar provided intellectual support for in-house testing and validation. Subsequently, we submitted the proposal for approval.

She said the kit ImCOV-Ag has very high sensitivity and specificity and can detect all variants of COVID-19.

The ICMR has approved the test kits based on the RMRC's internal validation and a third party's (an expert group from Kerala) report on efficacy and accuracy.

IMGENEX, CEO, Dr Sujay Singh said they started work on the kit in June 2021 and ICMR has approved it on Thursday following certain procedures.

He said with existing facilities, the firm can manufacture 2 lakh kits which can be ramped up to 20 lakh kits per month. Singh said that the kit is likely to be available in the market in two months.

Since it is the first such kit in eastern India, the states in this region can easily avail the facility. Singh said the market price of the kit will be lower than others now available in the market.

The ICMR, has so far validated as many as 150 Antigen based Rapid Test Kits (including 31 revalidations), sources in the health department said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus

First Published: Jan 29 2022 | 1:26 PM IST

Next Story